A P Pharma licenses nausea drug to Rhei Pharma in China PharmaBiz
A P Pharma, Inc. and Rhei Pharmaceuticals, Inc. announced that A.P. Pharma has granted an exclusive license to Rhei Pharmaceuticals to develop and sell APF530 in Greater China, which for the purposes of this agreement includes China, Taiwan, Hong Kong and Macau.
Area residents warned of smoke danger The Eureka Reporter
Due to wildfires in Humboldt and Trinity counties, the North Coast Unified Air Quality Management District warns that nearby populations may be subjected to considerable concentrations of smoke.
First case of bird flu confirmed in Greece and more From the Wilderness Publications
October 18, 2005 Residential Natural Gas Prices (CA) (read this story) Higher natural gas bills will start hitting California in October - by Michael Liedtke, AP (read this story) Fearing Heat Costs, Many Take Preventive Action - by Pam Belluck And Sarah Kershaw, New York Times (read this story) Genuine Elections - by Ron Resnick (read
FDA Approves New Label for VYTORINR ezetimibe/simvastatin Business Wire via Yahoo! Finance
WHITEHOUSE STATION, N.J. & KENILWORTH, N.J.----Merck/Schering-Plough Pharmaceuticals announced today that the U.S. Food and Drug Administration has approved the inclusion of new data in the product label that showed VYTORIN® was more effective than Crestor® at lowering LDL "bad" cholesterol at all doses compared, ranging from the usual recommended starting doses to the maximum approved doses .
Clinical Data From REVLIMIDR Study in Myelodysplastic Syndromes Reported in New England Journal of Medicine FinanzNachrichten
SUMMIT, N.J., Oct. 4 /PRNewswire-FirstCall/ -- The New England Journal of Medicine today published final results of a Celgene Corporation sponsored Phase II trial evaluating REVLIMID(R) (lenalidomide) as an oral therapy for patients with myelodysplastic syndromes (MDS) with transfusion- dependent anemia and deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
The danger in dining Milwaukee Journal Sentinel
When Colleen Pfaff was a toddler, her father forgot to wash his hands after handling blue cheese for a salad, and lifted
Long-Term Data Demonstrated Significantly Better Patient Adherence to COPAXONER Versus Interferons in Multiple RedNova
A retrospective follow-up analysis of an ongoin
Updated REVLIMID result presented at Int'l Lymphoid Conference Antara News
(Full text of a statement. Contact details follow below.)
TamifluR In Ample Supply For Prevention & Treatment Of Seasonal Flu Medical News Today
Roche announced today that its prescription antiviral medication Tamiflu(R) (oseltamivir phosphate) will be in ample supply during the 2006-2007 flu season in pharmacies across the U.S., with more than double the stock available last season. Tamiflu is indicated for the treatment and prevention of influenza in adults and in children 1 year and older. [click link for full article]
Cytokinetics Reports Data For Ispinesib In Recurrent And/or Metastatic Head And Neck Squamous Cell Carcinoma Medical News Today
Cytokinetics, Incorporated (Nasdaq: CYTK) announced results from a planned interim analysis following Stage 1 of a two-stage Phase II clinical trial of ispinesib administered as monotherapy in the treatment of patients with recurrent and/or metastatic head and neck squamous cell carcinoma (RMHNSC). [click link for full article]

Nutritional Management of Nausea / Vomiting
Nutritional Management of Nausea / Vomiting. Nutritional management of treatment side effects:. There is more to nutrition during cancer and cancer therapy
Recommendations for the evaluation and management of nausea and
Evaluation and management of nausea and vomiting in early pregnancy (less than or equal to 20 weeks gestation). Austin (TX): University of Texas at Austin,
The management of nausea and vomiting in clinical oncology.
The management of nausea and vomiting in clinical oncology. Craig JB, Powell BL. The development of cisplatin and the use of intensive combination
Management of Nausea and Vomiting in Cancer and Cancer Treatment
Management of Nausea and Vomiting in Cancer and Cancer Treatment Paul J. Hesketh, MD, Caritas St. Elizabeth's Medical Center of Boston/Tufts University
Symptom Management & Palliative Care : BC Cancer Agency
In this section you will find information on pain management, nausea management, anorexia/cachexia syndrome, bowel care, and dyspnea. Will I Suffer Much?


The management of nausea and vomiting in clinical oncology.
The management of nausea and vomiting in clinical oncology. Craig JB, Powell BL. The development of cisplatin and the use of intensive combination
Management of Nausea and Vomiting in Cancer and Cancer Treatment
Management of Nausea and Vomiting in Cancer and Cancer Treatment Paul J. Hesketh, MD, Caritas St. Elizabeth's Medical Center of Boston/Tufts University
Symptom Management & Palliative Care : BC Cancer Agency
In this section you will find information on pain management, nausea management, anorexia/cachexia syndrome, bowel care, and dyspnea. Will I Suffer Much?
Management of Nausea and Vomiting - Breast Cancer on Yahoo! Health
Management of Anticipatory Nausea. There are several things patients can do to prevent nausea and vomiting. First and foremost, make sure you receive and
An open study of methotrimeprazine in the management of nausea and
Methotrimeprazine is a phenothiazine antipsychotic used in palliative care for the management of terminal agitation and nausea/vomiting but there is only
Comparison of three outpatient regimens in the management of
Comparison of three outpatient regimens in the management of nausea and vomiting in pregnancy. Fadi A BSAT, Despina E HOFFMAN, David E SEUBERT
Granisetron: An Update on its Clinical Use in the Management of
However, the management of nausea and vomiting has improved greatly in recent years following the introduction of the 5-HT3-receptor antagonists,
IngentaConnect A review of dolasetron as management of nausea and
Dolasetron is a serotonin type 3 (5-HT3)-receptor antagonist with potent antiemetic effects in the management of nausea and vomiting.